Aldeyra Therapeutics Provides Corporate Update and Announces First Quarter 2017 Financial Results

Go back to Aldeyra Therapeutics Provides Corporate Update and Announces First Quarter 2017 Financial Results

Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.37/Share

May 15, 2017 7:39 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.37), versus ($0.51) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More